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Key points:  
 
• Diastolic dysfunction in heart failure patients is evident from stiffening of the 
passive properties of the ventricular wall. 
• Increased actomyosin interactions may significantly limit diastolic capacity, 
however direct evidence is absent. 
• From experiments at the cellular and whole organ level, in humans and rats, we 
show that actomyosin-related force development contributes significantly to high 
diastolic stiffness in environments where high ADP and increased diastolic [Ca2+] 
are present, such as the failing myocardium. 
• Our basal study provides a mechanical mechanism which may partly underlie 
diastolic dysfunction. 
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Abstract 
Heart failure (HF) with diastolic dysfunction has been attributed to increased myocardial 
stiffness that limits proper filling of the ventricle. Altered cross-bridge interaction may 
significantly contribute to high diastolic stiffness, but this has not been shown thus far. 
Cross-bridge interactions are dependent on cytosolic [Ca2+] and the regeneration of ATP 
from ADP. Depletion of myocardial energy reserve is a hallmark of HF leading to ADP 
accumulation and disturbed Ca2+-handling. Here, we investigated if ADP elevation in 
concert with increased diastolic [Ca2+] promotes diastolic cross-bridge formation and force 
generation and thereby increases diastolic stiffness. ADP dose-dependently increased force 
production in the absence of Ca2+ in membrane-permeabilized cardiomyocytes from human 
hearts. Moreover, physiological levels of ADP increased actomyosin force generation in the 
presence of Ca2+ both in human and rat membrane-permeabilized cardiomyocytes. Diastolic 
stress measured at physiological lattice spacing and 37°C in the presence of pathological 
levels of ADP and diastolic [Ca2+] revealed a 76±1% contribution of cross-bridge 
interaction to total diastolic stress in rat membrane-permeabilized cardiomyocytes. 
Inhibition of creatine kinase (CK), which increases cytosolic ADP, in enzyme-isolated 
intact rat cardiomyocytes impaired diastolic re-lengthening associated with diastolic Ca2+-
overload. In isolated Langendorff-perfused rat hearts, CK-inhibition increased ventricular 
stiffness only in the presence of diastolic [Ca2+]. We propose that elevations of intracellular 
ADP in specific types of cardiac disease, including those where myocardial energy reserve 
is limited, contribute to diastolic dysfunction by recruiting cross-bridges even at low Ca2+ 
and thereby increase myocardial stiffness. 
 
Abbreviations  
HF, Heart failure; CK, Creatine kinase; PCr, Phosphocreatine; LVEDP, Left ventricle end-diastolic 
pressure; IDCM, idiopathic dilated cardiomyopathy; Fpas, Passive tension; ADP-Ftotal, ADP-
stimulated total tension; ADP-Fact, ADP-active tension; Ca2+-Ftotal, Ca2+-stimulated total tension; 
Ca2+-Fact, Ca2+-active tension; EC50, ADP- or Ca2+-sensitivity (at which half of Fact is reached); ktr, 
Ca2+-ADP dependent rate of force redevelopment; PV, Pressure-volume; DNFB, 2,4-dinitro-1-
fluorobenzene; SERCA, Sarcoplasmic reticulum Ca2+-ATPase 
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Introduction 
Heart failure (HF) is a clinical syndrome defined as the inability of the heart to sufficiently 
supply blood to organs and tissues (McMurray & Pfeffer, 2005). While contractile 
dysfunction is present in about half of the HF patient population almost all patients show 
impaired diastolic function (McMurray & Pfeffer, 2005; Borlaug & Paulus, 2011). 
Pathophysiological mechanisms which have been related with diastolic dysfunction involve 
alterations of the passive properties of the ventricular wall, including high titin-based 
myofilament passive stiffness and collagen deposition, and slow rates of myocardial 
relaxation due to increased myofilament Ca2+-sensitivity and impaired Ca2+-reuptake 
(Leite-Moreira, 2006; van Heerebeek et al., 2012; Hamdani & Paulus, 2013).  
Depletion of myocardial energy reserve represents a major cause of dysfunction of 
the failing human heart (Neubauer, 2007). In the healthy heart, creatine kinase (CK) 
catalyzes the transfer of phosphate from phosphocreatine (PCr) to ADP, thereby 
regenerating ATP, while preventing accumulation of cytosolic ADP (Allen & Orchard, 
1987). ATP is essential for cross-bridge cycling. As little as 0.1 mM ATP is sufficient for 
cross-bridge detachment and sarcomere relaxation (Cooke & Bialek, 1979). The relatively 
high myocardial in vivo ATP levels in both healthy (8-11 mM) and various pathological 
conditions (7-10 mM) (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007) indicate 
that reductions in ATP levels are unlikely to directly impair relaxation of the heart muscle. 
Notably, HF patients with diastolic dysfunction (Smith et al., 2006; Phan et al., 2009) and 
animal models of HF (Hamman et al., 1995; Spindler et al., 1998; Horn et al., 2001; He et 
al., 2007) show that the reduced PCr/ATP ratio (a parameter of myocardial energy reserve 
measured in vivo) is mostly explained by a severe reduction in PCr (up to 50%) rather than 
changes of ATP (≤25%). Reducing PCr or experimental inhibition of CK activity is 
causally linked to the development of HF, as it elevates left ventricle end-diastolic pressure 
(LVEDP), reduces contractile reserve and increases mortality in rats (Hamman et al., 1995; 
Tian et al., 1997a; Horn et al., 2001). Activity of CK isoforms is decreased by 50% in 
animal models of HF (Khuchua et al., 1989; Nascimben et al., 1995; Neubauer et al., 
1995). The consequence of low PCr and/or a reduced CK activity is that cytosolic levels of 
ADP will increase. Indeed, increases in [ADP] of >50% have been reported in several 
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animal models of HF (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007). Selectively 
increasing ADP levels without altering cytosolic ATP levels has been shown to increase 
LVEDP and limit myocardial relaxation in rats (Tian et al., 1997a; Tian et al., 1997b). 
These studies support the idea that limited myocardial energy reserve via elevations of 
ADP may represent a likely cause of diastolic dysfunction. However the exact 
pathophysiological mechanism has not been elucidated. 
Intriguingly, ADP can stimulate tension generation, in the absence of Ca2+, in 
membrane-permeabilized rabbit skeletal muscle fibers (Shimizu et al., 1992) and bovine 
cardiac muscle (Fukuda et al., 1996; Fukuda et al., 1998). These findings indicate that ADP 
accumulation, as a consequence of disturbed myocardial energy reserve, may lead to 
incomplete relaxation during diastole caused by residual actomyosin interactions. However, 
in HF, the accumulation of ADP occurs concomitantly with disturbed Ca2+-handling 
(Beuckelmann et al., 1992; Shannon et al., 2003; Undrovinas et al., 2010). The effects of 
elevated intracellular ADP and high Ca2+ levels on human myofilament function that exist 
during the diastolic phase are currently not known. We hypothesize that in failing hearts 
enhanced cross-bridge formation and force generation, as a result of increased levels of 
ADP and diastolic [Ca2+] increase diastolic stiffness.  
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Methods 
Ethical Approval 
Human samples were obtained after written informed consent and with approval of St 
Vincent’s Hospital (#H03/118) and from the Human Research Ethics Committee of the 
University of Sydney (#159401). The investigation conforms with the principles outlined in 
the Declaration of Helsinki (1997). All animal experiments were performed with approval 
of the Animal Care and Use Committee of the VU University Medical Center (Amsterdam) 
and UK Home Office and local ethical review. 
 
Myocardial human samples 
Human left ventricular (LV) tissue was obtained during heart transplantion surgey from 
end-stage failing patients with idiopathic dilated cardiomyopathy (IDCM). Tissue was 
immediately frozen and stored in liquid nitrogen. 
 
Isometric force measurements in membrane-permeabilized single human 
cardiomyocytes 
Small human cardiac tissue samples (N=3) were thawed in relaxing solution and 
cardiomyocytes were mechanically isolated by tissue disruption as described previously 
(van der Velden et al., 1998). Cardiomyocytes were chemically permeabilized by 
incubation for 5 minutes in relaxing solution containing 0.5% (v/v) Triton-X100 and glued 
between a force transducer and a piezoelectric motor. Isometric force measurements were 
subsequently performed on single cardiomyocytes at a sarcomere length of 2.2 μm. 
Absolute force values were normalized to cardiomyocyte cross-sectional area and 
expressed as developed tension (in kN/m2). Passive tension (Fpas) was determined by 
allowing the cardiomyocyte to shorten by 30% of its length in relaxing solution. ADP-
stimulated total tension was determined by activating the cardiomyocyte at 10 mM ADP 
(ADP-Ftotal, Figure 1A). Similarly, Ca2+-stimulated total tension was determined by 
activating the cardiomyocyte at 32 μM Ca2+ (Ca2+-Ftotal; Figure 1A). Active tension (Ca2+-
Fact or ADP-Fact) was calculated as Fact=Ftotal-Fpas. In addition, the rate of force 
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redevelopment (ktr) was determined using a slack-restretch test as follows: after steady 
state force was reached, cardiomyocytes were allowed to shorten to 70% of their original 
length within 1 ms and then re-stretched to the original length after 30 ms. A single 
exponential was fitted to determine the rate constant of force redevelopment: ktr was 
determined at maximal and submaximal [Ca2+] in the presence of ADP to assess cross-
bridge cycling kinetics. 
 
Experimental solutions 
The composition of all solutions was calculated based on a computer program similar to 
that described previously (Papp et al., 2002). The pH of all solutions was adjusted to 7.1 at 
15ºC with KOH and ionic strength was adjusted to 180 mM with KCl. The relaxing 
solution contained 2 mM free Mg2+, 1 mM MgATP, 20 mM EGTA, 10 mM BES and 14.5 
mM PCr (P7936, Sigma). Several activating solutions were prepared: 1) Ca2+-activating 
solution consisted of 2 mM free Mg2+, 1 mM MgATP, 20 mM EGTA, 10 mM BES and 32 
μM free Ca2+. Ca2+-activating solutions with lower free [Ca2+] were obtained by mixing of 
the Ca2+-activating and relaxing solutions and assuming an apparent stability constant of 
the Ca2+ -EGTA complex of 106.35; 2) ADP-activating solutions (in the absence of free 
Ca2+) contained 2 mM free Mg2+, 1 mM MgATP, 20 mM EGTA, 10 mM BES and MgADP 
in increasing concentrations from 1 to 10 mM; 3) Ca2+- activating solutions in the presence 
of ADP consisted of 2 mM free Mg2+, 1 mM MgATP, 20 mM EGTA, 10 mM BES, 
MgADP concentrations from 0.02 to 6 mM and free Ca2+ from 1 to 32 μM. PCr was 
omitted from the activating solutions to preserve the MgADP/MgATP ratio. All force 
measurements were performed at 15ºC. [ATP] was maintained constant at 1 mM to avoid 
rigor cross-bridge formation (reported to occur when [ATP] falls below 0.1 mM (Cooke & 
Bialek, 1979)) and consecutively increased the [ADP] from 1 to 10 mM. We used a 
maximum [ADP] of 10 mM, since ADP-stimulated tension was maximal at 10 mM ADP 
with 1 mM ATP in bovine cardiac muscle (Fukuda et al., 1996; Fukuda et al., 1998). 
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Data analysis of isometric force measurements 
Ca2+- and/or ADP-force relations were determined by a non-linear fit procedure using a 
modified Hill equation using KaleidaGraph version 3.6 (Synergy Software, Reading, PA) 
as follows accordingly: 
 
P (Ca2+) / P0 = [Ca2+ nH / (K nH + [Ca2+]nH) 
 
P (ADP) / P0 = [ADP]nH / (K nH + [ADP]nH) 
 
P (Ca2+-ADP) / P0 = [Ca2+-ADP]nH / (K nH + [Ca2+-ADP]nH) 
 
where P is steady-state force. P0 denotes the steady isometric force at either saturating 
[Ca2+], high [ADP] or both saturating [Ca2+] and high [ADP], nH describes the steepness of 
the relationship, and K represents the [Ca2+] and/or [ADP] at which force is half-maximal 
(0.5 x P0). Myofilament Ca2+- and/or ADP-sensitivity is denoted as EC50. 
 
Isolation of intact rat ventricular cardiomyocytes 
Intact rat cardiomyocytes were isolated using collagenase digestion of hearts as described 
previously (King et al., 2011). Briefly, adult wild-type male Wistar rats (N=7) weighing 
~300 grams were euthanized with isoflurane and hearts were quickly removed and rinsed in 
cold isolation-Tyrode solution (composition: 130 mM NaCl, 5.4 mM KCl, 3 mM 
NaPyruvate, 25 mM HEPES, 0.5 mM MgCl2, 0.33 mM NaH2PO4, 22 mM glucose) 
containing 0.2 mM EGTA (Tyrode-EGTA) and pH 7.4. The heart was then cannulated via 
the aorta to the Langendorff apparatus and perfused for 2 min with Tyrode-EGTA at 37ºC. 
Thereafter, the heart was perfused with enzyme-Tyrode solution consisting of Tyrode 
solution, 1.2 mg/ml collagenase (Type II, 265 U/mg; Worthington Biochemical, NJ, USA) 
and 50 μM CaCl2 for a period of 7 min. The right ventricle and atria were removed, and the 
LV was cut into small pieces and triturated with a plastic Pasteur pipette for 3 min in 
stopping buffer solution 1 (SB-1; composition: Tyrode solution, 0.6 mg/ml collagenase, 
100 μM CaCl2 and 10 mg/ml bovine serum albumin (BSA)). The cell suspension was 
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filtered through a 300 µm nylon mesh filter into a 50 ml Falcon tube and centrifuged for 1 
min at 27x g (20-23ºC). The pellet containing cardiomyocytes was resuspended in SB 
solution 2 (SB-2; composition: Tyrode solution, 250 μM CaCl2 and 10 mg/ml BSA) and 
incubated for 10 min in a water bath at 37ºC allowing cells to settle. The supernatant was 
discarded and cardiomyocytes were resuspended in SB solution 3 (SB-3; containing Tyrode 
solution, 500 μM CaCl2 and 10 mg/ml BSA), incubated for 10 min at 37ºC and 
subsequently resuspended in experimental Tyrode (used for measurements of intact 
cardiomyocytes), consisting of 1.2 mM CaCl2, 137 mM NaCl, 5.4 mM KCl, 0.33 mM 
NaH2PO4, 0.57 mM MgCl2, 5 mM HEPES and 5.6 mM glucose. Cardiomyocytes were 
used within the first 6h of isolation. 
 
Isometric force measurements in membrane-permeabilized single rat cardiomyocytes 
Single cardiomyocytes isolated by collagenase digestion from adult wild-type male Wistar 
rats (N=4) were used. Cardiomyocytes were chemically permeabilized with 0.5% (v/v) 
Triton-X100 as indicated above for human and isometric force measurements were 
performed at sarcomere lengths of 2.2 μm. Experimental temperature and solution 
conditions were similar as previously described for human samples. Ca2+-force relations 
without and with ADP, and the rate of cross-bridge cycling was determined as previously 
described for human samples. 
 
Diastolic stress measurements in membrane-permeabilized rat cardiomyocytes 
Single cardiomyocytes isolated by collagenase digestion from adult wild-type male Wistar 
rats (N=5) were used. Cardiomyocytes were chemically permeabilized with 0.5% (v/v) 
Triton-X100 as indicated above and isometric force measurements were performed in 
single cardiomyocytes stretched from 1.8 to 2.4 μm sarcomere lengths. Experiments were 
performed at 15ºC to replicate conditions currently employed to study diastolic 
stiffness/stress and at a higher, more physiological temperature of 37ºC. Since membrane-
permeabilization causes myofilament lattice expansion, experiments were also performed 
with the osmotic agent dextran T500 (4%, w/v) that compresses the myofilament lattice to 
physiological levels (Irving et al., 2000). Additionally, 30 μM of the cross-bridge inhibitor 
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blebbistatin was used to assess the contribution of cross-bridge formation to passive stress. 
Force generation was normalized to cardiomyocyte cross-sectional area and expressed as 
diastolic stress (in kN/m2). The composition and characterization of all 4 conditions is 
displayed in Table 1. To mimic conditions currently in use to study diastolic 
stiffness/stress, experiments were performed at 15ºC in the 1) absence and 2) presence of 
blebbistatin. To approach in vivo disease conditions measurements were performed at 37ºC 
and with Dextran T500 in the 3) absence and 4) presence of blebbistatin. Because 
blebbistatin is photosensitive, experiments were performed in the dark. To ensure whether 
total absolute tension values were absent of protocol artefacts due to substantial differences 
in cross-sectional area that could artificially increase or decrease diastolic stress, all cross-
sectional measurements were done in solutions without dextran. Cross-sectional area did 
not statistically differ between conditions 1 to 4 (342.8±18, 370.1±39, 354±22 and 350±36 
kN/m2/μm, respectively). 
 
Cardiomyocyte shortening and Ca2+-transient of intact rat cardiomyocytes 
Unloaded shortening and Ca2+-transients of intact rat cardiomyocytes (n=15 to 20) were 
monitored following field stimulation (1Hz, 4 ms, 7V), and sarcomere shortening as well as 
relaxation kinetics were visualized using a video-based sarcomere length (SL) detection 
system (IonOptix corporation). Wild-type rat cardiomyocytes were incubated in Tyrode 
solution containing 1 µM Fura-2-AM for 15 min and rinsed for a period of 10 min in 
Tyrode. Cardiomyocytes were placed into a temperature-controlled (37ºC) chamber with 
platinum electrodes to electrically stimulate cells. Single cardiomyocytes were randomly 
selected (without spontaneous contraction) and continuously perfused with Tyrode buffer. 
After 3-5 min field stimulation sarcomere shortening as well as relaxation kinetics and 
Ca2+-transient were monitored. Cardiomyocytes loaded with Fura-2-AM were excited at 
340 and 380 nm with emission monitored at 510 nm. The F340/F380 ratio was used as a 
measure of cytosolic [Ca2+]. From the monitored Ca2+-transient, Ca2+-release and -reuptake 
velocity, the time to reach peak systolic Ca2+ and the time constant of Ca2+ decline (tau) 
were determined.  
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Experimental protocol for unloaded rat cardiomyocyte measurements 
To test the hypothesis that ADP accumulation impairs myofilament function in 
cardiomyocytes with intact membrane, a protocol was established using a low dose of an 
irreversible inhibitor of CK, iodoacetamide. Specifically, 5 mM fresh iodoacetamide 
(I6125, Sigma) was dissolved in Tyrode buffer and perfused (at 1 ml/min) for 3 min, 
delivering a total dose of 15 μmoles/3 ml. This drug has well-characterized effects on the 
ATP-regeneration system, such that it significantly increases [ADP] without altering ATP, 
PCr, inorganic phosphate and pH levels in isolated perfused hearts (Tian et al., 1997a; Tian 
et al., 1997b). ADP is estimated to be lower than 73 μM at this dose range (Tian et al., 
1997a). 
 Two protocols were used to test the effects of CK-inhibition (Fig. 5). 
Cardiomyocytes were paced at 1Hz for 3-5 min with continuous perfusion with Tyrode 
solution (at 1 ml/min and 36±0.1ºC) to establish a steady state. Thereafter, a number of 
cells was either perfused for 3 min with a total dose of 15 μmoles/3 ml of iodoacetamide 
(Fig. 5A) or continuously perfused with Tyrode solution (Fig. 5C). Following 3 min 
treatment with iodoacetamide, perfusion with Tyrode solution was restored. Perfusion was 
limited to 3 min/ml with 5 mM of iodoacetamide, because the Ca2+-Fura signal deteriorated 
by longer exposure and/or greater concentration of drug. Control experiments to check for 
Ca2+-fluorescence demonstrated that iodoacetamide does not quench Ca2+ (data not shown). 
Measurements were averaged and analyzed in three phases as detailed in the legend of 
Figure 5. The control protocol was the same as the treatment protocol except that cells were 
continuously perfused with Tyrode solution. 
 
Isolated perfused Langendorff hearts: Diastolic pressure-volume relationships 
Adult wild-type male Wistar rats were euthanized by stunning and cervical dislocation and 
hearts quickly removed and rinsed in cold Krebs-Henseleit (KH) solution. Diastolic 
pressure-volume relationships were measured in hearts connected to a Langendorff 
apparatus and perfused with Ca2+-free KH solution gassed with 95% O2-5% CO2 at 37°C 
and pH 7.4. An inflatable balloon (filled with pre-boiled, degassed Milli-Q water) was 
placed in the left ventricle and the volume adjusted with a syringe pump dispensing at 400 
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μL/min. Balloon volume was inferred from dispensing rate and pressure was recorded 
continuously via a side port connected to a pressure transducer. Balloon volume was 
increased in cycles to elicit a series of pressures from 10-30 mmHg allowing the balloon to 
conform to the LV cavity surface; the final cycle to 30 mmHg was repeated and all diastolic 
pressure-volume data were obtained from it (LeGrice et al., 2012). 
The experimental procedures were as follows: diastolic pressure-volume 
relationship of Langendorff-perfused rat hearts were recorded after 60 min perfusion with 
Ca2+-free KH with (N=5 hearts) or without (N=6 hearts) 20 μM of the cell-permeant Ca2+-
chelator BAPTA-AM (Cambridge Bioscience, UK) dissolved in DMSO (final 
concentration <0.1%). Perfusion solution was then switched to a Ca2+-free KH containing 
20 μM 2,4-dinitro-1-fluorobenzene (DNFB; 42085, Sigma) dissolved in ethanol (final 
concentration <0.1%), for 30 min then PV measurements were repeated. DNFB is an 
irreversible inhibitor of CK which decreases the ATP/ADP ratio (Gercken & Schlette, 
1968). Because iodoacetamide inhibits enzymes of the glycolytic reaction (even though 
well-oxygenated hearts have normal glycolysis after iodoacetamide-treatment (Tian et al., 
1997a)), whereas DNFB does not (Westerblad & Lännergren, 1995), we wanted to ensure 
complete preservation of the glycolytic flux following long chemical inhibition of a 
multicellular system such as the whole heart. DNFB has been shown to produce similar 
effects in isolated cardiomyocytes as iodoacetamide (Fowler et al., 2014). 
 
Creatine Kinase activity 
CK activity levels were assessed using a commercial colorimetric assay kit (ab155901, 
Abcam) that detects kinase activity as low as 1 mU/ml (nmol/min/ml). Activity was 
assessed in freshly isolated cell suspensions from rat cardiomyocytes (N=3) as follows: 
from each single animal, two suspensions of isolated cells were treated (i.e. one treated 
with buffer (control) and another with 5 mM iodoacetamide) for 5 minutes, centrifuged for 
30 seconds at 27x g (37ºC) and supernatant discarded. The pellet containing 
cardiomyocytes was immediately frozen in liquid nitrogen and freeze-dried overnight. 
Assay was performed as specified by manufacturer supplied information. Similarly, CK 
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activity was evaluated in fresh rat cells from 3 animals without and in the presence of 20 
μM of DNFB. 
 
Statistical analysis 
Data analysis and statistics were performed using Prism version 6.0 (Graphpad Software, 
Inc., La Jolla, CA) and SAS/STAT® 9.2 (Statistical Analysis System Software, Institute 
Inc., Cary, NC, USA).  
Data are presented as mean ± SEM of all single cardiomyocytes per patient/animal 
or group. All data was tested for normality using the Shapiro-Wilk Test. Normality was 
assumed when p>0.05 and the variances were equal. Paired- and/or unpaired-sample 
Student’s t-Test was conducted when one variable was tested between 2 groups of data. 
Single classification analysis of variance (ANOVA) was performed when one variable was 
tested in more than 2 groups. When a significant difference was found in repeated measures 
1-way ANOVA, Bonferroni post hoc testing was used to determine the location of 
significant differences. When more than one variable was tested in more than 2 groups a 2-
way ANOVA was conducted followed by a Bonferroni post hoc test if significant 
differences were found. A linear mixed model was performed to gain insights into the 
individual trajectories of repeated measurements of each data group (e.g. intercepts and 
slopes) compared with controls. This model takes into account the repeated measurements 
within subjects. Each performed test is specified in Tables or Figure legends. The level of 
significance was set at p<0.05 and exact significance level (p values) are given in 
Supporting Tables 1 and 2. 
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Results  
ADP stimulates myofilament contraction in the absence of Ca2+ 
To assess whether ADP alone can induce contraction in human cardiac muscle, force 
produced by single membrane-permeabilized cardiomyocytes from human failing hearts 
was measured at increasing [ADP]. ADP caused force production in the absence of Ca2+ 
with maximal tension (ADP-Fact) achieved with 10 mM ADP and tension reaching 80±3% 
of maximal Ca2+-developed tension (Fig. 1A). Comparable to Ca2+, force-ADP relation 
curves show the common sigmoidal pattern, indicating cooperative activation (Fig. 1B). 
ADP-induced tension at 1 mM ADP amounted to 14±1% and nearly saturated at 8 mM 
ADP (94±3%). Half-maximal ADP-Fact (EC50) was 3.80±0.15 mM ADP (Fig. 1B). 
 
ADP increases myofilament Ca2+-sensitivity 
Myocardial ADP levels in animal models are reported in the range of 10-50 μM in health 
and of 40-140 μM in disease (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007), 
indicative that in vivo levels of ADP are incapable of myocardial activation since in vitro 
mM levels of ADP are required for force generation (Fig. 1B). Cardiomyocytes in vivo are 
activated by the cytosolic Ca2+ transient that varies from ~0.15 μM during diastole to a peak 
of ~1.6 μM in systole (Bers, 2002). We therefore investigated if elevation of ADP in 
concert with physiological levels of Ca2+ increases force generation in human membrane-
permeabilized cardiomyocytes (Fig. 2A). Physiological levels of ADP were chosen in the 
range of 20 and 100 μM. ADP shifted the Ca2+-force relation substantially to the left, 
indicative of increased Ca2+-sensitization of myofilaments (Fig. 2A). Indeed, as little as 20 
μM ADP significantly increased Ca2+-Fact generation, evident from the elevated Ca2+-
sensitivity compared with the Ca2+-force relation without ADP (EC50=1.69±0.10 and 
1.95±0.09 μM Ca2+, respectively). Our data suggests that conditions that promote elevation 
of myocardial ADP result in cross-bridge recruitment even at low Ca2+, supporting delayed 
muscle relaxation. 
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ADP slows cross-bridge detachment in the presence of Ca2+ 
The rate of myofilament contraction and relaxation is regulated by the rate of attachment 
and detachment of force producing cross-bridges, i.e. cross-bridge cycling. Therefore, the 
rate of force redevelopment (ktr, a measure of the rate of cross-bridge cycling) in the 
presence of Ca2+ and ADP was examined, and values were plotted against the 
corresponding isometric force (Fig. 2B). When Ca2+-activated isometric force rises with 
increasing [ADP] the ktr relationships shifted substantially to the right and downwards with 
significant differences found for relationships with supra-physiological ADP levels present 
(≥2 mM ADP; Supp Table 1). This suggests that force increases at the expense of slowing 
cross-bridge cycling (Fig. 2B), likely resulting from a population of strongly-bound cross-
bridges with slow detachment kinetics. This is consistent with significant increases in 
sarcomere stiffness (i.e. high residual force recovery) at [ADP] ≥20 μM, indicative for 
reduced actomyosin detachment and enhanced strain/force per each individual cross-bridge 
(Figs. 2C and 2D).  
To test whether the latter changes in myofilament Ca2+-sensitivity, cross-bridge 
cycling and residual force recovery (Fig. 2) are species-independent, similar experiments 
were performed in rat membrane-permeabilized cardiomyocytes in the presence of 100 μM 
ADP. Rat membrane-permeabilized cardiomyocytes present similar dependence to ADP as 
humans, such as increased myofilament Ca2+-sensitization, slower rates of cross-bridge 
cycling and high residual force recovery (Fig. 3).  
Together these data indicate that in membrane-permeabilized cardiomyocytes the 
combined presence of Ca2+ and physiological ADP levels increases cross-bridge stiffness, 
even at low Ca2+ levels, which could contribute to high sarcomere stiffness and reduce LV 
compliance during the diastolic phase. 
 
Re-evaluation of the influence of cross-bridges on in vitro diastolic stress with in vivo 
conditions 
In the last decade, numerous in vitro studies assessed the diastolic properties of human HF 
myocardium and no evidence was found for the possible contribution of cross-bridges to 
the high diastolic stiffness observed in disease (van Heerebeek et al., 2012; Hamdani & 
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Paulus, 2013). Nevertheless, the majority of the studies thus far have been based on 
membrane-permeabilized myocytes, where the relatively low experimental temperature 
(15ºC) in concert with sarcolemma digestion that causes lattice expansion and removes 
important differences in intracellular milieu (such as increased ADP levels), may largely 
underestimate cross-bridge interactions. To overcome some of these concerns we adjusted 
the protocol previously reported by King et al.(King et al., 2011), where diastolic stress 
was measured in rat membrane-permeabilized cardiomyocytes at 37ºC in the presence of 
the osmotic agent dextran to compress myofilament lattice restoring it to physiological 
conditions. By measuring cardiomyocyte diastolic stress, in the presence of diastolic [Ca2+] 
and [ADP] known to occur in disease with and without the cross-bridge inhibitor 
blebbistatin (30 μM), we were able to assess the contribution of cross-bridge formation to 
diastolic myocardial stress/stiffness. Please note that for the initial experiments in 
membrane-permeabilized cardiomyocytes from human (Fig. 2) and rat (Fig. 3) the 
temperature was set at 15ºC. This relatively low temperature was used to avoid preparation 
deterioration and maintain the stability of the muscle preparation during several long-
lasting series of activation. This was shown not to be problematic for the current 
experiments at 37ºC as a result of lower levels of activation in concert with a relatively 
brief protocol. 
Four protocols were performed in which rat membrane-permeabilized 
cardiomyocytes were stretched from 1.8 to 2.4 μm sarcomere length. Conditions used are 
presented in Table 1. A representative recording is presented in Figure 4A showing 
diastolic force generation measured at 37ºC. Note that force is generated at 37ºC, which is 
not seen in the other three conditions. Comparison of 15ºC and 15ºC+Blebbistatin 
confirmed the previous observations that cross-bridge contribution to diastolic stiffness is 
nearly absent at non-physiological conditions, with a statistical difference found at a 
sarcomere length of 2.4 μm (Fig. 4B). However, comparison of 37ºC with 
37ºC+Blebbistatin shows that the cross-bridge contribution is significantly higher, 
accounting for 76±1% of total diastolic stress averaged over all sarcomere lengths (Fig. 
4B). Together these data support that in intracellular environments where high ADP and 
increased diastolic [Ca2+] are present, such as in the failing myocardium, the actomyosin 
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contribution to high diastolic stiffness may be substantially higher than previously 
considered and potentially represent a pathophysiological mechanism of HF with impaired 
diastolic function. 
 
CK-inhibited rat cardiomyocytes show impaired relaxation and augmented contractility 
To investigate the impact of inactivated CK activity and the consequent increase in 
cytosolic ADP levels, as to replicate the cytosolic environment of HF myocardium, intact 
rat cardiomyocytes were perfused with the irreversible CK antagonist iodoacetamide (15 
μmoles/3 ml) during pacing at 1Hz and 37ºC. CK activity was inhibited by 38±7%. 
Contraction and Ca2+-transient were simultaneously recorded in control and iodoacetamide-
treated intact rat cardiomyocytes (Fig. 5). No significant alterations were observed between 
controls and iodoacetamide group at baseline (phase I) (Table 2, Supp Table 2 and Figs. 
5A-5G). Control cardiomyocytes remained stable throughout the entire protocol for all 
parameters analyzed, i.e. no significant alterations were observed, (compared from phase I 
to phase III) with the exception for decreases of systolic and amplitude Ca2+-signal, likely 
resulting from deterioration of the fluorescence signal over time (Table 2).  
From phase I (baseline) to phase II (initial perfusion with iodoacetamide), diastolic 
and systolic sarcomere length were significantly reduced by 14±2% and 38±6%, 
respectively (Fig. 5B and Table 2), and sarcomere shortening increased by 24±5% (Fig. 5E 
and Table 2). In addition, cardiomyocyte shortening time was significantly increased 
without a significant change in shortening velocity (Table 2). The contractile changes were 
not mediated by changes in Ca2+-transients, since there were no statistical alterations in 
diastolic Ca2+ (Fig. 5F) and the Ca2+-relaxation time constant (tau) (Fig. 5G) from phase I to 
II. 
Between phases II and III (after iodoacetamide perfusion) diastolic and systolic 
sarcomere lengths decreased significantly compared with baseline and phase II (Fig. 5B 
and Table 2). This was accompanied by 35±8% enhancement of sarcomere shortening 
compared with baseline (Fig. 5E). These latter contractile changes are associated with 
disturbed Ca2+-handling, which includes significant increases of diastolic Ca2+ (20±6%, 
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Fig. 5F) with prolongation of Ca2+-reuptake by 50±20% (tau) (Fig. 5G) compared with 
baseline (Table 2). 
 Together these data indicate that inhibiting CK, which elevates cytosolic ADP, in 
intact cardiomyocytes leads to impaired diastolic relaxation (i.e. limited diastolic re-
lengthening). Initially, these alterations are independent of changes in the Ca2+ transient, but 
prolonged CK-inhibition was associated with diastolic Ca2+-overload and slowing of Ca2+-
reuptake. 
 
CK-inactivation decreases ventricular compliance in the presence of diastolic Ca2+  
Tian et al.(Tian et al., 1997a; Tian et al., 1997b) have previously shown that myocardial 
ADP elevation increases LVEDP and impairs myocardial relaxation in isolated rat hearts. 
However, the authors argued against a role of Ca2+ and solely attributed the latter effects to 
high [ADP] (Tian et al., 1997a). To clarify whether ADP is the sole responsible factor for 
the reported increase in LVEDP, ventricular compliance was measured in isolated 
Langendorff-perfused rat hearts, in which CK was inactivated, in the absence and presence 
of the intracellular Ca2+-chelator BAPTA-AM. Diastolic pressure-volume (PV) 
relationships were performed in hearts arrested in Ca2+-free buffer following inhibition of 
CK with 2,4-dinitro-1-fluorobenzene (DNFB) and with BAPTA-AM (Fig. 6A). DNFB (20 
μM) inhibited CK activity reaction by 42±8%, i.e. about equal to iodoacetamide effect. 
Diastolic PV slope increased in hearts perfused with DNFB in Ca2+-free solution (Fig. 6B), 
indicative of reduced LV compliance. In other hearts, addition of BAPTA-AM (20μM) to 
Ca2+-free solution (-Ca2++BATPA) did not change diastolic PV slope compared to -Ca2+ 
solution (Fig. 6B), but prevented the increase in diastolic PV slope following DNFB (Fig. 
6B). To understand whether Ca2+ alone could account for the increased PV slope, 200 μM 
of caffeine was added to induce Ca2+-release (Fig. 6B). The PV slope only showed a 
modest increase compared to CK-inhibition (Fig. 6B). Together, these results indicate that 
the combined presence of CK-inactivation and diastolic [Ca2+] are needed for the observed 
decline in ventricular compliance in whole heart preparations.  
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Iodoacetamide and DNFB do not target myofilament proteins 
To exclude direct effects of iodoacetamide or DNFB on myofilament proteins, membrane-
permeabilized rat cardiomyocytes were measured before and after incubation with both 
CK-inhibitors. Maximal, submaximal Ca2+-tension and Fpas were not changed in the 
presence of both inhibitors, indicative that both CK-inhibitors do not directly target 
myofilament protein functions (Table 3). No phosphorylation differences after 
iodoacetamide treatment in the intact rat cardiomyocytes (Figure 5) were found for the 
myofilament regulators of Ca2+-sensitivity of force, including cardiac myosin-binding 
protein C, cardiac troponin I and myosin light chain, and the regulator of diastolic stiffness 
titin (data not shown). Altogether, these data strongly suggest that the observed CK-
inhibition effects on diastolic impairment (Figs. 5 and 6) are due to its effects on 
myocardial energy reserve and independent of alterations of myofilament proteins. 
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Discussion  
Diastolic function is both dependent on the rate of myocardial relaxation and passive 
properties of the wall that allow proper filling of the ventricle. In this study we provide 
evidence that synergistic actions of ADP and Ca2+ increase actomyosin interactions which 
elevate myocardial stiffness and limit proper filling of the heart. Our findings show that 
increased cross-bridge interactions may lead to diastolic dysfunction, in environments with 
elevated ADP and increased Ca2+, evidenced by high cardiomyocyte stiffness and impaired 
diastolic re-lengthening, associated with limited ventricular compliance. In human and rat 
membrane-permeabilized cardiomyocytes, physiological levels of ADP led to an increased 
myofilament Ca2+-sensitivity and stiffness, indicating a slowing or incomplete ventricular 
relaxation with high diastolic stiffness. In support, CK-inactivation limited restoration of 
diastolic length in intact rat cardiomyocytes and decreased ventricular compliance in whole 
rat hearts. Altogether these findings indicate that the increased [ADP] as observed in 
cardiac diseases, in which the metabolic function is compromised, significantly contributes 
to impaired diastolic function. 
 
Elevated ADP and Ca2+ contribute to diastolic dysfunction 
Combining studies in human and rat cardiomyocytes and hearts, we show that high ADP 
and increased Ca2+ enhance diastolic stress. In human and rat membrane-permeabilized 
cardiomyocytes a combination of Ca2+ and physiological ADP levels increased Ca2+-
sensitivity and cross-bridge stiffness (Figs. 2A and 2D, and Figs. 3A and 3C). Similar 
findings in the presence of supra-physiological levels of ADP have been shown to elevate 
Ca2+-sensitivity and sarcomere stiffness in both skeletal rabbit myofibrils (Lu et al., 2001; 
Tesi et al., 2002; Siththanandan et al., 2006) and rat trabeculae (Martyn et al., 2007). 
Additionally, in intact rat cardiomyocytes CK-inhibition limited diastolic relaxation (Fig. 
5B). LV compliance also declined in isolated rat hearts (Fig. 6). Similarly, it was previously 
shown by Tian et al.(Tian et al., 1997a; Tian et al., 1997b) that myocardial ADP 
accumulation increases LVEDP and impairs myocardial relaxation in isolated rat hearts. 
However, these authors argued that these changes are Ca2+-independent (Tian et al., 
1997a). Our findings instead support the hypothesis that Ca2+ exacerbates the decline in LV 
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compliance in the presence of ADP. This is shown by the observation that buffering Ca2+ 
prevented the decrease in compliance during CK-inactivation (Fig. 6B). Conversely, a low 
concentration of caffeine (200 μM), to induce diastolic Ca2+-release, showed a modest 
increase in PV slope compared to CK-inhibition (Fig. 6B). Thus, Ca2+ alone cannot 
completely account for the observed decline of LV compliance. These data suggest that in 
the absence of ADP resting diastolic Ca2+ has a relatively small contribution to diastolic 
stiffness and that ventricular compliance only declines in the presence of diastolic Ca2+ and 
high ADP caused by an active cross-bridge component. We provide evidence that high 
ADP and Ca2+-dependent cross-bridge formation imposes high myocardial diastolic 
stiffness associated with greater than normal filling pressure, which contribute to diastolic 
dysfunction. 
 
Augmented contractility following elevations of ADP and Ca2+ 
On the basis of the observed diastolic impairment of intact rat cardiomyocytes we would 
expect a reduced fractional shortening, resulting from restricted recruitment of the Frank-
Starling reserve. This would decrease the preload-induced force of contraction. In contrast, 
contractility was increased as evidenced by enhanced shortening capacity of intact rat 
cardiomyocytes following CK-inactivation (Fig. 5E). The greater than normal contractility 
can be explained by the increased Ca2+-sensitivity of force production induced by 
physiological levels of ADP (Figs. 2A and 3A) and the Ca2+-overload state promoted by 
CK-inactivation (Figs. 5F and 5G, and Table 2). Notably, our analysis reveals that the early 
inotropic response following CK-inactivation (phase II) is not caused by disturbed Ca2+-
transient (Figs. 5F and 5G, and Table 2) and thus explained by the ADP-induced increase 
of myofilament Ca2+-sensitivity (Figs. 2A and Fig. 3A). However, prolonged CK-inhibition 
(phase III) still leads to increased contractility, but also significantly impairs diastolic re-
lengthening (Fig. 5B), both of which are likely caused by systolic and diastolic Ca2+-
overload (Figs. 5F and 5G, and Table 2), respectively. Our results support the theory that 
CK-inactivation by increases of cytosolic ADP stimulates a Ca2+-overload state. The Ca2+-
overload can result from: 1) the high Ca2+-sensitivity promoted by ADP at the 
myofilaments; because the myofilaments are the main source for the buffering of Ca2+ 
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during the cardiac cycle (Bers, 2001), evidence from animal models supports that high 
myofilament Ca2+-sensitivity increases cytosolic Ca2+-binding with altered Ca2+-
homeostasis in animals (Baudenbacher et al., 2008; Schober et al., 2012); and/or 2) the 
high [ADP/ATP] ratio caused by ADP accumulation that reduces the free energy released 
from ATP hydrolysis (∆GATP). Since the sarcoplasmic reticulum Ca2+-ATPase, and other 
sarcolemmal pumps, including the Na+/K+-ATPase, operate close to their theoretical 
thermodynamic limits, the rise of [ADP] will favor diastolic Ca2+ rise (Allen & Orchard, 
1987). However one cannot exclude that iodoacetamide also has an effect on Ca2+-release 
via the ryanodine receptor as was shown in skeletal muscle from rabbits (Menshikova et al., 
2000). Hence, in our experiments ‘artificial’ elevation of Ca2+ that is not coupled to CK-
inhibition may also be present. 
 
Enhanced actomyosin interactions lead to high diastolic stress 
It has been proposed that expression of the stiffer titin isoform or its altered 
phosphorylation represents a major contributor to high diastolic stiffness observed in HF 
patients with diastolic dysfunction (van Heerebeek et al., 2012; Hamdani & Paulus, 2013). 
Within these studies, there is no evidence to support a role for altered cross-bridge 
interaction to high diastolic stiffness (van Heerebeek et al., 2012; Hamdani & Paulus, 
2013). In the majority of the studies membrane-permeabilized cardiomyocytes and muscle 
strips, with thick- and thin-filament extraction by KCl and KI, have been employed to study 
passive properties of HF myocardium (van Heerebeek et al., 2012; Hamdani & Paulus, 
2013). There are however limitations to the latter approaches that need to be addressed: 1) 
KCl and KI treatment is designed to assess the contribution of collagen to sarcomere 
stiffness as it removes thick- and thin-filament anchors in the sarcomere, and thereby 
abolishes any contribution of the actomyosin interaction (Granzier & Irving, 1995); 2) 
chemical digestion of the sarcolemma in membrane-permeabilized cardiomyocytes causes 
myofilament lattice expansion (and less approximation of myosin towards actin) that 
decreases force generation (McDonald & Moss, 1995; Konhilas et al., 2002); 3) the 
relatively low temperature (15ºC) used in the experiments reduces cross-bridge active 
force, shortening velocity and power (Ranatunga & Coupland, 2010); 4) rapid shortening 
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and re-lengthening procedures mechanically detach myosin from actin (Huxley & 
Simmons, 1971; Brenner, 1991); and importantly 5) membrane-permeabilized 
cardiomyocytes lack important contributors in the intracellular milieu of normal and failing 
intact cardiomyocytes. These include the in vivo diastolic Ca2+ and cytosolic ADP. King et 
al.(King et al., 2011) has recently reported that cross-bridges account for up to ~30% of 
diastolic stress at a sarcomere length of 2.1 μm using mouse membrane-permeabilized 
cardiomyocytes measured at 37ºC in the presence of dextran to normalize lattice spacing. In 
the present study we adapted this protocol to evaluate the cross-bridge contribution to 
diastolic stress in rat membrane-permeabilized cardiomyocytes under disease conditions, 
including those where metabolic function is affected that elevates ADP in the presence of 
diastolic Ca2+, and showed that cross-bridges greatly contribute to diastolic stress (Fig. 4). 
Our data support the idea that cross-bridges may slow myocardial relaxation and impose 
high diastolic stiffness in disease, and in concert with titin and other diastolic mediators, 
contribute to diastolic dysfunction in HF patients. Importantly our results support the notion 
that the diastolic phase is not purely a passive process, but is accompanied by active stress. 
 
Limitations 
At present, we are unable to directly control intracellular ADP concentration in the intact 
cardiomyocytes and whole heart preparations. To increase cytosolic ADP, we opted for the 
use of two well known drugs that inhibit the CK reaction, i.e. iodoactemide and DNFB. 
Iodoacetamide allows us to estimate ADP elevations due to its well-characterized effects on 
the ATP-regeneration system (Tian et al., 1997a). Based on previous findings using similar 
amounts of iodoactemide (Tian et al., 1997a), ADP is estimated not to exceed 73 μM in our 
experiments, while ATP, PCr, inorganic phosphate and pH levels are unaltered. A 
limitation of iodoactemide which makes it unsuitable for whole heart experiments, is that it 
unspecifically targets enzymes of the glycolytic reaction (Tian et al., 1997a). This is not 
problematic in single cells because of the short duration of the experiment (3 min). In 
contrast, this might be detrimental in the whole heart experiments, which required longer 
periods of CK-inhibition (30 min). Therefore, DNFB was used in those experiments, as it 
does not target enzymes of the glycolytic pathway (Westerblad & Lännergren, 1995). 
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However, using DNFB we are unable, to our knowledge, to carefully estimate the expected 
intracellular ADP concentration. We believe that overall the effects of both drugs are 
interchangeable between experiments, which is partly supported by similar inhibition of the 
CK reaction (~40%). 
 
Conclusion 
Based on our experimental data, we propose that conditions which elevate myocardial ADP 
and Ca2+ contribute to diastolic dysfunction by increasing residual actomyosin interactions. 
This leads to high cardiomyocyte stiffness and impaired relaxation, associated with limited 
ventricular compliance. Our study provides a mechanistic basis for how the elevated ADP 
and diastolic Ca2+-overload can contribute to diastolic dysfunction in HF patients. 
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Translational Perspective 
Here we show that actomyosin-related force development may be an important contributor 
to high diastolic stiffness and may explain the development of diastolic dysfunction in 
environments where high ADP and increased diastolic [Ca2+] are present, such as in the 
failing myocardium. These findings establish a clear link between deficits of myocardial 
energy reserve and disturbed Ca2+-handling, which together leads to inappropriate cross-
bridge formation and high diastolic stiffness. These findings may provide insight in how 
energy-sparing therapies (that reduce cellular ATP usage), such as beta-blockers, 
angiotensin-receptor blockers and angiotensin converting enzyme inhibitors, improve 
symptoms and reduce mortality in congestive HF patients (McMurray & Pfeffer, 2005). 
Our data highlight the need for more targeted therapies aimed at lowering myocardial ADP 
levels to improve the prognosis of human HF. 
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Table 1. Solution’s composition of the 4 conditions tested. 
Condition [Ca2+] 
(μM) 
Dextran  Blebbistatin
(μM) 
PCr 
(mM) 
MgATP 
(mM) 
MgADP 
(μM) 
Unphysiological       
15ºC <0.001 - - 14.5 10 - 
15ºC+Blebbistatin <0.001 - 30 14.5 10 - 
Physiological       
37ºC 0.15 4% - - 10 100 
37ºC+Blebbistatin 0.15 4% 30 - 10 100 
PCr, Phosphocreatine; pH was adjusted to 7.1 at 15ºC and at 37ºC with KOH and ionic strength was 
adjusted to 180 mM with KCl; 2 mM free Mg2+, 10 mM MgATP, 7 mM EGTA and 100 mM BES 
were present in all solutions; Experiments performed at 15ºC were used to mimic conditions 
currently employed to study diastolic stiffness, while experiments at 37ºC better recapitulate the in 
vivo diseased heart.
Table 2. Cardiomyocyte shortening and Ca2+-transient in rat cardiomyocytes with and without iodoacetamide. 
 Phase I Phase II Phase III 
 Ctrl-group IA-group Ctrl-group IA-group Ctrl-group IA-group 
Shortening       
Diastolic SL (μm) 1.85±0.01 1.85±0.01 1.85±0.01 1.83±0.01§ 1.85±0.01 1.81±0.01‡#
Shortening velocity (μm/s) -4.9±0.3 -4.5±0.4 -5.0±0.2 -5.1±0.3 -5.2±0.3 -5.3±0.3‡ 
Time to peak shortening  (s) 0.060±0.004 0.060±0.003 0.061±0.004 0.065±0.003§ 0.061±0.004 0.066±0.003‡ 
Sarcomere shortening (%) 8.2±0.5 7.3±0.5 8.3±0.4 9.0±0.6§ 8.7±0.4 9.4±0.6‡
Systolic SL (μm) 1.70±0.01 1.71±0.02 1.70±0.01 1.66±0.02§ 1.69±0.01 1.63±0.01‡#
Relaxation velocity (μm/s) 3.5±0.2 3.2±0.3 3.6±0.2 3.5±0.3 3.7±0.2 3.6±0.3 
Time to 90% relaxation (s) 0.15±0.01 0.17±0.01 0.15±0.01 0.17±0.01 0.15±0.01 0.21±0.03 
Ca2+-transient       
Diastolic Ca2+ (F340/380) 1.00±0.09 0.98±0.08 0.99±0.09 1.05±0.08 0.96±0.08 1.17±0.08‡ 
Time to peak Ca2+ release (s) 0.028±0.002 0.028±0.001 0.028±0.001 0.031±0.002 0.030±0.001 0.036±0.003‡
Systolic Ca2+ (F340/380) 1.58±0.15 1.57±0.14 1.51±0.15§ 1.54±0.15 1.39±0.12‡ 1.56±0.12 
Ca2+ amplitude (F340/380) 0.58±0.08 0.60±0.07 0.49±0.07§ 0.49±0.07§ 0.42±0.06‡# 0.38±0.06‡# 
Tau (s) 0.095±0.005 0.094±0.006 0.094±0.005 0.096±0.007 0.096±0.007 0.132±0.015‡#
Ctrl, Control; IA, Iodoacetamide; SL, sarcomere length. Data was compared using repeated measures 1-way ANOVA followed by Bonferroni post 
hoc test. p<0.05 was considered significant; §1-way ANOVA post hoc test phase I versus corresponding phase II; ‡1-way ANOVA post hoc test 
phase I versus corresponding phase III; #1-way ANOVA post hoc test phase II versus corresponding phase III; Detailed statistics in Table S2. 7 
heart samples from adult wild-type male Wistar rats were used; 17 to 18 (Ctrl-group) and 17 to 20 (IA-group) cardiomyocytes were analysed.
 
 
 
Table 3. Response of Ca2+-stimulated maximal and submaximal contraction without and 
with iodoacetamide or DNFB, in left ventricular rat membrane-permeabilized 
cardiomyocytes at sarcomere length 2.2 μm. 
Sample before incubation  after incubation   N/n 
Iodoacetamide (5 mM)   N=3, n=11 
32 μM Ca2+-Fact (kN/m2) 22.3±2.7 21.0±2.3  
4.0 μM Ca2+-Fact (kN/m2) 17.1±2.0 16.2±1.8  
    
 Fpas (kN/m2) 1.7±0.2 1.6±0.2  
DNFB (20 μM)   N=3, n=9 
32 μM Ca2+-Fact (kN/m2) 20.0±1.5 19.6±1.5  
4.0 μM Ca2+-Fact (kN/m2) 14.0±1.5 13.8±1.5  
    
 Fpas (kN/m2) 1.2±0.2 1.1±0.2  
N, number of rats; n, number of cardiomyocytes. Cardiomyocytes were measured before and after incubation 
with 5 mM iodoacetamide or 20 μM DNFB, in relaxing solution, for 5 or 30 minutes, respectively. Data was 
compared using a paired-sampled Student’s t-Test. p<0.05 was considered significant.
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Fig. 1. ADP causes force production in human left ventricular membrane-
permeabilized cardiomyocytes. A, Representative tension recordings of a single 
cardiomyocyte isolated from a end-stage failing human heart at 2.2 μm sarcomere length 
during maximal Ca2+ (32 μM) and ADP-activation (10 mM) at 15ºC and 1 mM ATP. B, 
Normalized force-ADP relationship of human cardiomyocytes. 9 to 11 cardiomyocytes 
from 3 failing human hearts were used. 
 
Fig. 2. Ca2+-sensitivity and cross-bridge stiffness increases in the presence of ADP in 
human left ventricular membrane-permeabilized cardiomyocytes. A, Ca2+-force 
relations were constructed without and with [ADP] at 15ºC and 1 mM ATP. Light blue 
panel depicts the free [Ca2+] range in in vivo cardiomyocytes (i.e. [~0.15-1.6 μM]). Data 
was compared using 1-way ANOVA followed by Bonferroni post hoc test. All data show 
significant differences compared with ‘control (no [ADP])’. B, Normalization of ktr as a 
function of Ca2+-activated isometric force. The ktr-force relationship shifted to the right 
and downwards with [ADP] (R2=0.93, R2=0.88, R2=0.76, R2=0.65, R2=0.55 and R2=0.81, 
from 0-6 mM ADP respectively). A linear mixed model assuming force as a continuous 
variable indicates significant differences for the interactions of 2 and 6 mM ADP 
compared with ‘control (no [ADP])’. C, Residual force recording tracings. Top: Residual 
force recordings after a slack-restretch test at high Ca2+ (32 μM) without or with 
increasing [ADP]. Recording of 2 mM ADP is omitted from the graph due to overlap 
with 6 mM ADP recording. Bottom: Length changes of piezoelectric motor by 30% of 
cardiomyocyte’s original length is depicted. Residual force was calculated from the initial 
force recovery reached after the length change (dashed lines) and normalized to each total 
steady-state force reached before length change. Measurements are normalized to each 
corresponding total force. D, Significant increases in residual force enhancement at high 
Ca2+ without or with various [ADP] are observed after a slack-restretch test, indicative 
for increased sarcomere stiffness. Values are normalized to each corresponding total 
relative force reached before the slack-restretch procedure. Data was compared using 1-
way ANOVA followed by Bonferroni post hoc test. *p<0.05 versus ‘control (no [ADP])’. 
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9 to 11 cardiomyocytes from 3 end-stage human failing hearts were used for each ADP 
concentration. 
 
Fig. 3. Ca2+-sensitivity and cross-bridge stiffness increases in the presence of ADP in 
left ventricular rat membrane-permeabilized cardiomyocytes. A, Ca2+-force relations 
were constructed without and with 0.1 mM ADP at sarcomere lengths of 2.2 μm and at 
15ºC and 1 mM ATP. Data was compared using paired t-Test. Ca2+-sensitivity of force 
significantly increases in the presence of 0.1 mM ADP compared with ‘control (no 
[ADP])’. B, Normalization of ktr as a function of Ca2+-activated isometric force. The ktr-
force relationship shifted to the right and downwards with 0.1 mM ADP (R2=0.79 and 
R2=0.95, ‘control (no [ADP])’ and 0.1 mM ADP, respectively). C, Significant increases 
in residual force enhancement at high Ca2+ with 0.1 mM ADP are observed after a slack-
restretch test compared with ‘control (no [ADP])’, indicative for increased sarcomere 
stiffness. Values are normalized to each corresponding total relative force reached before 
the slack-restretch procedure. Data was compared using paired t-Test. *p<0.05 versus 
‘control (no [ADP])’. 12 cardiomyocytes from 4 adult wild-type male Wistar rat hearts 
were used.  
  
Fig. 4. Re-evaluation of the influence of cross-bridges on in vitro diastolic stress with 
in vivo conditions. A, Representative force recording example of a left ventricular single 
rat cardiomyocyte moved from a non-activating solution at 37ºC with 14.5 mM PCr and 
<0.001 μM Ca2+ to an activating solution at 37ºC in the presence of diastolic Ca2+ (0.15 
μM), dextran (4%), 100 μM ADP and 10 mM ATP. Upper tracing: solutions used in the 
protocol are depicted. Middle: Length changes of piezoelectric motor is depicted. For 
measurement of passive force, a slack-restretch procedure of 30% of cardiomyocyte’s 
original length is performed. Bottom: Force recording after a slack-restretch test is 
depicted. Diastolic tension value was taken from the 30% slack procedure over a period 
of 10 seconds (period from 30 to 40 seconds). B, Tension-sarcomere length relations are 
depicted from left ventricular rat membrane-permeabilized cardiomyocytes. Rat 
cardiomyocytes were stretched from 1.8 to 2.4 μm and diastolic stress was measured in 
the following conditions: 37ºC (Dextran (4%), diastolic Ca2+ (0.15 μM) and 100 μM 
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ADP) in the absence (dark exponential curve) and presence of Blebbistatin (37ºC + 
Blebbistatin; dashed dark exponential curve); and 15ºC (with 14.5 mM PCr and <0.001 
μM Ca2+) in the absence (gray exponential curve) and presence of Blebbistatin (15ºC + 
Blebbistatin; dashed gray exponential curve). All solutions contained 10 mM ATP. 
Comparison of 37ºC with 37ºC+Blebbistatin shows that the cross-bridge contribution 
accounts for 76±1% of total diastolic stress averaged over all sarcomere lengths. Data 
was compared using unpaired t-Test within independent groups measured at similar 
temperature for each individual sarcomere length. *p<0.05 versus ‘in the presence of 
Blebbistatin’. 12 to 16 cardiomyocytes from 5 adult wild-type male Wistar rat hearts 
were used. 
 
Fig. 5. Creatine kinase-inhibited cells show decreased diastolic length but 
augmented contractility in intact left ventricular rat cardiomyocytes. Example of 
sarcomere length and Ca2+-transient recordings of left ventricular single unloaded intact 
rat cardiomyocytes with iodoacetamide treatment at 1Hz pacing. A, Iodoacetamide 
treatment. Phase (I). Baseline. Measurements just prior to iodoacetamide administration 
(cardiomyocytes paced for 3-5 minutes). Iodoacetamide (start-stop). Perfusion (at 1 
ml/min) was performed for 3 min with 5 mM iodoacetamide resulting in a total dose of 
15 μmoles/3 ml. Phase (II). Initial perfusion with iodoacetamide. Cardiomyocytes were 
allowed 1 min to adjust to iodoacetamide perfusion and measurements were recorded for 
4 min. Phase (III). Post-iodoacetamide perfusion. Measurements were carried out 
ranging from 3-10 min  depending on cardiomyocytes survival. Phase III was typified by 
diastolic [Ca2+] increases as well as systolic and diastolic sarcomere length alterations. 
Note: example of cell death in the last 100 seconds of recording. B, Alterations of 
diastolic and systolic sarcomere length from phase I (baseline), throughout phase II 
(initial perfusion with iodoacetamide) to phase III (after iodoacetamide perfusion), in 
iodoacetamide (IA)-treated cells. Relative sarcomere length changes compared with 
phase I of each corresponding group. *versus Phase I. C, Control recording protocol (no 
treatment) tracing. Similar to (A) except, instead of iodoacetamide treatment, 
cardiomyocytes were perfused with buffer solution. Note: during both protocols 
cardiomyocytes were continuously perfused with buffer solution (at 1 ml/min) with the 
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exception being the 3 minute period of iodoacetamide perfusion in (A). D, Alterations of 
diastolic and systolic sarcomere length from phase I (baseline), throughout phase II 
(similar perfusion time as phase II in (B)) to phase III (similar perfusion time as phase III 
in (B)), in control cells. Relative sarcomere length changes compared with phase I of 
each corresponding group. E, % increase change of sarcomere shortening. F, % increase 
of diastolic Ca2+-level. G, % delay of the Ca2+-relaxation time constant, tau, indicative of 
Ca2+-reuptake. Figures 5E, 5F and 5G are all % changes relative to phase I in IA-treated 
cells. Corresponding data are presented in Table 2. *p<0.05 versus Phase I. Data was 
compared using 1-way ANOVA followed by Bonferroni post hoc test. 7 heart samples 
from adult wild-type male Wistar rats were used; 17 to 18 (Ctrl-group) and 17 to 20 (IA-
group) cardiomyocytes were analysed. 
 
Fig. 6. Left ventricle (LV) compliance declines following creatine kinase (CK)-
inactivation in isolated rat hearts. A, Mean diastolic pressure-volume (PV) relationship 
in Langendorff-perfused hearts arrested in Ca2+-free buffer without and with inhibition of 
CK. Hearts (N=6) were perfused with nominally Ca2+-free solution for 60 min then the 
diastolic PV relationship was measured (-Ca2+). 2,4-dinitro-1-fluorobenzene (DNFB; 20 
μM) was then perfused for a further 30 min and measurements repeated (-Ca2++DNFB). 
In a separate group of hearts (N=5), the intracellular Ca2+-chelator BAPTA-AM (20μM) 
was added to -Ca2+ solution and perfused for 60 min (-Ca2++BAPTA), followed by 
perfusion for 30 min with DNFB (-Ca2++DNFB+BAPTA). B, Slope of the diastolic PV 
relationship. DNFB reduced left ventricle compliance in -Ca2+ solution, shown by a 
steeper diastolic PV relationship. BAPTA did not change diastolic PV slope compared to 
-Ca2+. However, BAPTA prevented the increase in diastolic PV slope following DNFB 
perfusion. In a separate group of hearts (N=2), addition of low concentration of caffeine 
(200 μM) in Ca2+-free solution appears to be sufficient to cause diastolic Ca2+-leak, 
indicative from the increase in diastolic PV slope. Although to a lesser extent than -
Ca2++DNFB. Data was compared using 2-way repeated measures ANOVA followed by 
Bonferroni post hoc test. *p<0.05. 
 
 






